Transurethral resection of bladder tumour (TURBT) for bladder cancer (BC) is an underappreciated common urological procedure. TURBT outcomes are highly variable, and results are dependent on judgement and surgical skill.
To perform a narrative review and identify optimal best practice in TURBT including preparation, choice of equipment, procedural steps, surgical technique, and management of difficult scenarios and complications.
Medline, Embase, and the Cochrane Central Register of Controlled Trials were searched. Important studies were identified and reviewed by an international panel of urologists representing major urological societies and guideline panels with a record of academic publication in this field. In areas where the group identified a lack of evidence or agreement, discussions took place until a consensus was reached.
A total of 814 studies were identified and 43 were included. The majority were retrospective (level of evidence 3), with only two prospective randomised trials. Four broad themes were identified, which formed the basis for the review: (1) the role of TURBT within the overall management of BC, (2) TURBT techniques, (3) measurement of outcomes including quality control and checklists, and (4) postoperative management. Familiarity with all aspects of the procedure is necessary to minimise morbidity and improve oncological outcomes. Development of new instruments and techniques, and prospective audit of TURBT outcomes are important future goals.
TURBT is a common and challenging operation with known variable outcomes. To reduce these variations and optimise outcomes, best practice based on evidence and expert opinion is recommended.
Transurethral resection of bladder tumour (TURBT) is a common but deceptively difficult urological operation. Optimal outcomes depend on experience and surgical skill. An international group of experienced TURBT surgeons review critical aspects of the procedure and share best practice to stimulate further discussion.
European urology oncology. 2020 Jul 16 [Epub ahead of print]
Hugh Mostafid, Ashish M Kamat, Siamak Daneshmand, Joan Palou, John A Taylor, James McKiernan, James Catto, Marko Babjuk, Mark Soloway
Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK. Electronic address: ., Department of Urology, MD Anderson Cancer Center, Houston, TX, USA., Department of Urology, USC/Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Department of Urology, Fundacio Puigvert, Universidad Autonoma de Barcelona, Barcelona, Spain., Department of Urology, University of Kansas Medical Center, Kansas City, KS, USA., Department of Urology, New York Presbyterian Hospital/Columbia University Medical Center, New York City, NY, USA., Academic Urology Unit, University of Sheffield, Sheffield, UK., Department of Urology, Hospital Motol, Second Faculty of Medicine, Charles University, Prague, Czech Republic., Division of Urology, Memorial Hospital, Hollywood, FL, USA.
PubMed http://www.ncbi.nlm.nih.gov/pubmed/32684515